
Purdue Pharma to Be Dissolved Under $50B+ Opioid Settlement
Purdue Pharma, maker of OxyContin, is set to be dissolved and replaced by Knoa Pharma by week's end as a sweeping $50bn+ settlement resolving thousands of opioid lawsuits takes effect. A federal judge delivered the final criminal sentence Tuesday, clearing the way for the deal. The Sackler family, which owns Purdue, will pay up to $7bn over 15 years. The settlement comes as the opioid crisis has been linked to more than 900,000 US deaths since 1999. Many victims expressed frustration, arguing the sentence provides no real justice for individuals.

